Global In Vitro Toxicology Testing Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by In Vitro Toxicology Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global In Vitro Toxicology Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Cell culture technology
  • 1.4.3 High-throughput technology
  • 1.4.4 Cellular imaging technology
  • 1.4.5 Toxicogenomics
• 1.5 Market by Application
  • 1.5.1 Global In Vitro Toxicology Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Pharmaceuticals & biopharmaceuticals industry
  • 1.5.3 Cosmetics and household products industry
  • 1.5.4 Food industry
  • 1.5.5 Chemicals industry
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global In Vitro Toxicology Testing Market Perspective (2015-2026)
• 2.2 Global In Vitro Toxicology Testing Growth Trends by Regions
  • 2.2.1 In Vitro Toxicology Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 In Vitro Toxicology Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 In Vitro Toxicology Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 In Vitro Toxicology Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key In Vitro Toxicology Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top In Vitro Toxicology Testing Players by Market Size
  • 3.1.1 Global Top In Vitro Toxicology Testing Players by Revenue (2015-2020)
  • 3.1.2 Global In Vitro Toxicology Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global In Vitro Toxicology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global In Vitro Toxicology Testing Market Concentration Ratio
  • 3.2.1 Global In Vitro Toxicology Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by In Vitro Toxicology Testing Revenue in 2019
• 3.3 In Vitro Toxicology Testing Key Players Head office and Area Served
• 3.4 Key Players In Vitro Toxicology Testing Product Solution and Service
• 3.5 Date of Enter into In Vitro Toxicology Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global In Vitro Toxicology Testing Historic Market Size by Type (2015-2020)
• 4.2 Global In Vitro Toxicology Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global In Vitro Toxicology Testing Market Size by Application (2015-2020)
• 5.2 Global In Vitro Toxicology Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America In Vitro Toxicology Testing Market Size (2015-2020)
• 6.2 In Vitro Toxicology Testing Key Players in North America (2019-2020)
• 6.3 North America In Vitro Toxicology Testing Market Size by Type (2015-2020)
• 6.4 North America In Vitro Toxicology Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe In Vitro Toxicology Testing Market Size (2015-2020)
• 7.2 In Vitro Toxicology Testing Key Players in Europe (2019-2020)
• 7.3 Europe In Vitro Toxicology Testing Market Size by Type (2015-2020)
• 7.4 Europe In Vitro Toxicology Testing Market Size by Application (2015-2020)

8 China

• 8.1 China In Vitro Toxicology Testing Market Size (2015-2020)
• 8.2 In Vitro Toxicology Testing Key Players in China (2019-2020)
• 8.3 China In Vitro Toxicology Testing Market Size by Type (2015-2020)
• 8.4 China In Vitro Toxicology Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan In Vitro Toxicology Testing Market Size (2015-2020)
• 9.2 In Vitro Toxicology Testing Key Players in Japan (2019-2020)
• 9.3 Japan In Vitro Toxicology Testing Market Size by Type (2015-2020)
• 9.4 Japan In Vitro Toxicology Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia In Vitro Toxicology Testing Market Size (2015-2020)
• 10.2 In Vitro Toxicology Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia In Vitro Toxicology Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia In Vitro Toxicology Testing Market Size by Application (2015-2020)

11 India

• 11.1 India In Vitro Toxicology Testing Market Size (2015-2020)
• 11.2 In Vitro Toxicology Testing Key Players in India (2019-2020)
• 11.3 India In Vitro Toxicology Testing Market Size by Type (2015-2020)
• 11.4 India In Vitro Toxicology Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America In Vitro Toxicology Testing Market Size (2015-2020)
• 12.2 In Vitro Toxicology Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America In Vitro Toxicology Testing Market Size by Type (2015-2020)
• 12.4 Central & South America In Vitro Toxicology Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 SGS
  • 13.1.1 SGS Company Details
  • 13.1.2 SGS Business Overview
  • 13.1.3 SGS In Vitro Toxicology Testing Introduction
  • 13.1.4 SGS Revenue in In Vitro Toxicology Testing Business (2015-2020))
  • 13.1.5 SGS Recent Development
• 13.2 Covance
  • 13.2.1 Covance Company Details
  • 13.2.2 Covance Business Overview
  • 13.2.3 Covance In Vitro Toxicology Testing Introduction
  • 13.2.4 Covance Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.2.5 Covance Recent Development
• 13.3 Bio-Rad Laboratories
  • 13.3.1 Bio-Rad Laboratories Company Details
  • 13.3.2 Bio-Rad Laboratories Business Overview
  • 13.3.3 Bio-Rad Laboratories In Vitro Toxicology Testing Introduction
  • 13.3.4 Bio-Rad Laboratories Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.3.5 Bio-Rad Laboratories Recent Development
• 13.4 Qiagen
  • 13.4.1 Qiagen Company Details
  • 13.4.2 Qiagen Business Overview
  • 13.4.3 Qiagen In Vitro Toxicology Testing Introduction
  • 13.4.4 Qiagen Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.4.5 Qiagen Recent Development
• 13.5 GE Healthcare
  • 13.5.1 GE Healthcare Company Details
  • 13.5.2 GE Healthcare Business Overview
  • 13.5.3 GE Healthcare In Vitro Toxicology Testing Introduction
  • 13.5.4 GE Healthcare Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.5.5 GE Healthcare Recent Development
• 13.6 Eurofins Scientific
  • 13.6.1 Eurofins Scientific Company Details
  • 13.6.2 Eurofins Scientific Business Overview
  • 13.6.3 Eurofins Scientific In Vitro Toxicology Testing Introduction
  • 13.6.4 Eurofins Scientific Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.6.5 Eurofins Scientific Recent Development
• 13.7 Merck
  • 13.7.1 Merck Company Details
  • 13.7.2 Merck Business Overview
  • 13.7.3 Merck In Vitro Toxicology Testing Introduction
  • 13.7.4 Merck Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.7.5 Merck Recent Development
• 13.8 Thermo Fisher
  • 13.8.1 Thermo Fisher Company Details
  • 13.8.2 Thermo Fisher Business Overview
  • 13.8.3 Thermo Fisher In Vitro Toxicology Testing Introduction
  • 13.8.4 Thermo Fisher Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.8.5 Thermo Fisher Recent Development
• 13.9 Charles River Laboratories International
  • 13.9.1 Charles River Laboratories International Company Details
  • 13.9.2 Charles River Laboratories International Business Overview
  • 13.9.3 Charles River Laboratories International In Vitro Toxicology Testing Introduction
  • 13.9.4 Charles River Laboratories International Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.9.5 Charles River Laboratories International Recent Development
• 13.10 Catalent
  • 13.10.1 Catalent Company Details
  • 13.10.2 Catalent Business Overview
  • 13.10.3 Catalent In Vitro Toxicology Testing Introduction
  • 13.10.4 Catalent Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 13.10.5 Catalent Recent Development
• 13.11 Cyprotex
  • 10.11.1 Cyprotex Company Details
  • 10.11.2 Cyprotex Business Overview
  • 10.11.3 Cyprotex In Vitro Toxicology Testing Introduction
  • 10.11.4 Cyprotex Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 10.11.5 Cyprotex Recent Development
• 13.12 Promega
  • 10.12.1 Promega Company Details
  • 10.12.2 Promega Business Overview
  • 10.12.3 Promega In Vitro Toxicology Testing Introduction
  • 10.12.4 Promega Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 10.12.5 Promega Recent Development
• 13.13 Gentronix Limited
  • 10.13.1 Gentronix Limited Company Details
  • 10.13.2 Gentronix Limited Business Overview
  • 10.13.3 Gentronix Limited In Vitro Toxicology Testing Introduction
  • 10.13.4 Gentronix Limited Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 10.13.5 Gentronix Limited Recent Development
• 13.14 Ascendance Biotechnology
  • 10.14.1 Ascendance Biotechnology Company Details
  • 10.14.2 Ascendance Biotechnology Business Overview
  • 10.14.3 Ascendance Biotechnology In Vitro Toxicology Testing Introduction
  • 10.14.4 Ascendance Biotechnology Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 10.14.5 Ascendance Biotechnology Recent Development
• 13.15 MB Research Laboratories
  • 10.15.1 MB Research Laboratories Company Details
  • 10.15.2 MB Research Laboratories Business Overview
  • 10.15.3 MB Research Laboratories In Vitro Toxicology Testing Introduction
  • 10.15.4 MB Research Laboratories Revenue in In Vitro Toxicology Testing Business (2015-2020)
  • 10.15.5 MB Research Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer